Plain-English translation of NCT06320132 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The BLANDISH study is developing an artificial intelligence system designed to help doctors better care for patients with spontaneous intracranial hemorrhage — a serious type of brain bleeding. Researchers will analyze medical data from patients treated in the neuro-intensive care unit to teach the AI to recognize patterns and predict which patients are at highest risk, so doctors can provide more targeted, personalized care. This could help improve survival rates and reduce complications for future patients.
Brain bleeding in the hospital remains a serious condition with poor outcomes, even though doctors follow established treatment guidelines. Current treatment approaches haven't significantly improved patient survival over many decades, so researchers believe an AI system that can analyze large amounts of patient data may uncover better, personalized treatment strategies that guidelines alone cannot provide.
You likely qualify if…
You likely don't qualify if…
If you join this study, your doctors will collect and store your medical information and hospital records as part of your regular care in the neuro-intensive care unit. The researchers will then use your data (along with data from up to 2,000 other patients) to train and test an AI system designed to predict outcomes and guide treatment decisions. You won't need to do anything extra — the study simply involves researchers analyzing the medical care you're already receiving.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Italy
Sponsor
IRCCS Ospedale San Raffaele
Enrollment target
~2,000 participants
Started
March 2024
Primary completion
December 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Francesca Guzzo, MD
IRCCS Ospedale San Raffaele
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.